✦ LIBER ✦

Role of TSC–mTOR pathway in diabetic nephropathy

✍ Scribed by Ken Inoki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dysregulation of the TSC-mTOR pathway in

✍ Inoki, Ken; Corradetti, Michael N; Guan, Kun-Liang 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

TSC2: filling the GAP in the mTOR signal

✍ Yong Li; Michael N. Corradetti; Ken Inoki; Kun-Liang Guan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 289 KB

The role of the TSC-22 (−396) A/G varian

✍ Fumiaki Sugawara; Yuichiro Yamada; Rie Watanabe; Nobuhiro Ban; Kazumasa Miyawaki 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 212 KB

The variation of AkT/TSC1–TSC1/mTOR sign

✍ Ping Chen; Hongtao Yan; Yin Chen; Zhonglin He 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 846 KB

The mTOR pathway is highly activated in

✍ Hiroyuki Mori; Ken Inoki; Kohsuke Masutani; Yu Wakabayashi; Kyoko Komai; Ryusuke 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 845 KB

Role of glycosaminoglycans in diabetic n

✍ Giovanni Gambaro; Bruno Baggio 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 849 KB